News
In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.
VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...
6d
New Scientist on MSN3D printing could enable a long-term treatment for type 1 diabetesSmall, 3D-printed devices, designed to be implanted directly under the skin, could allow people with type 1 diabetes to ...
16d
ScienceAlert on MSNNew Treatment May Cure Severe Type 1 Diabetes, Study FindsA dozen volunteers with severe type 1 diabetes showed clear improvements in their condition 12 months after receiving a ...
Teplizumab offers a completely different approach. Instead of simply replacing insulin, it targets the immune attack that causes type 1 diabetes.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results